Vivo Capital as of Sept. 30, 2017
Portfolio Holdings for Vivo Capital
Vivo Capital holds 29 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding | 14.9 | $74M | 2.0M | 37.38 | |
Aclaris Therapeutics (ACRS) | 14.9 | $74M | 2.9M | 25.81 | |
Ascendis Pharma A S (ASND) | 12.9 | $64M | 1.8M | 36.25 | |
Nabriva Therapeutics | 6.7 | $33M | 4.1M | 8.19 | |
Kala Pharmaceuticals | 5.3 | $27M | 1.2M | 22.84 | |
Verona Pharma Plc ads (VRNA) | 4.6 | $23M | 1.5M | 15.35 | |
Strongbridge Bioph shs usd | 4.1 | $20M | 3.0M | 6.90 | |
Selecta Biosciences | 4.1 | $20M | 1.1M | 18.25 | |
Codexis (CDXS) | 4.1 | $20M | 3.1M | 6.65 | |
Eiger Biopharmaceuticals | 4.0 | $20M | 1.8M | 11.00 | |
Aimmune Therapeutics | 3.9 | $19M | 777k | 24.79 | |
Advanced Accelerat spon ads each rep 2 ord | 3.4 | $17M | 249k | 67.62 | |
Kadmon Hldgs | 2.3 | $11M | 3.3M | 3.35 | |
Amyris | 1.8 | $9.0M | 2.8M | 3.20 | |
Zai Lab (ZLAB) | 1.8 | $8.8M | 325k | 27.00 | |
Aurinia Pharmaceuticals (AUPH) | 1.5 | $7.6M | 1.2M | 6.27 | |
Soleno Therapeutics | 1.5 | $7.6M | 15M | 0.52 | |
Agile Therapeutics | 1.4 | $6.8M | 1.5M | 4.46 | |
Regenxbio Inc equity us cm (RGNX) | 1.1 | $5.4M | 164k | 32.95 | |
Foamix Pharmaceuticals | 1.0 | $4.7M | 855k | 5.55 | |
Trevena | 0.9 | $4.4M | 1.7M | 2.55 | |
Biopharmx | 0.8 | $4.1M | 14M | 0.29 | |
Sierra Oncology | 0.8 | $3.8M | 2.4M | 1.55 | |
Crispr Therapeutics (CRSP) | 0.5 | $2.7M | 149k | 17.87 | |
Revance Therapeutics (RVNC) | 0.4 | $2.1M | 77k | 27.55 | |
Akari Therapeutics | 0.4 | $2.1M | 346k | 6.14 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $2.0M | 300k | 6.73 | |
Sunesis Pharmaceuticals Inc Ne | 0.2 | $970k | 500k | 1.94 | |
Soleno Therapeutics Inc Wt S E w | 0.0 | $113k | 944k | 0.12 |